Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344 with cholesterol and triglycerides lowering activity. MB-07811 is an agonist of liver-targeted THR-β.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 100,500 | |||
10 mg | 在庫あり | ¥ 148,500 | |||
25 mg | 在庫あり | ¥ 226,500 | |||
50 mg | 在庫あり | ¥ 317,000 |
説明 | MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344 with cholesterol and triglycerides lowering activity. MB-07811 is an agonist of liver-targeted THR-β. |
別名 | VK-2809 |
分子量 | 514.98 |
分子式 | C28H32ClO5P |
CAS No. | 852948-13-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (87.38 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MB-07811 852948-13-1 Endocrinology/Hormones Thyroid hormone receptor(THR) MB07811 VK2809 MB 07811 VK-2809 VK 2809 Inhibitor inhibitor inhibit